Evaluation of Serum Pregnancy Associated Plasma Protein-A & Plasma D-Dimer in Acute Coronary Syndrome.

INTRODUCTION Acute coronary syndrome (ACS), a spectrum comprising unstable angina pectoris, ST Elevated Myocardial Infarction (STEMI) & Non ST Elevated Myocardial Infarction (NSTEMI) is the major cause of presentation in Emergency Department today. Though ECG and cardiac enzymes are used for diagnosis, they mislead the diagnosis sometimes and delay in treatment initiation. This leads us to search certain new parameters which reflect the pathophysiology of ACS. Markers of plaque stability like Pregnancy Associated Plasma Protein-A and D-Dimer, a marker of ongoing thrombosis are found to be better markers in early diagnosis. AIM To evaluate the diagnostic competence of PAPP-A and D-Dimer in acute coronary syndrome over CK-MB and to compare with the inflammatory marker High Sensitive C-Reactive Protein (hs-CRP) which is associated with atherosclerosis. MATERIALS AND METHODS Fifty patients presenting with acute onset of chest pain to Emergency Department with or without ECG changes served as cases and 50 healthy people served as controls. Serum PAPP-A is measured by Enzyme Linked Immunosorbent Assay (ELISA), D-Dimer and hs-CRP by using Latex Turbidimetry method. RESULTS A statistical significant difference of PAPP-A and D-Dimer was noted between the ACS and controls (p < 0.001) whereas CK-MB shows no much difference (p 0.09). Statistically significant positive correlation is noted between parameters. CONCLUSION PAPP-A marker of plaque instability and D-Dimer marker of ongoing thrombosis are raised in acute coronary syndrome and thus can be considered as one of the marker in ACS for diagnosis.

• Publication year

  2016

• Venue

  Journal of clinical and diagnostic research : JCDR

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.7860/JCDR/2016/14432.7011PMID 26894054PMCID PMC4740581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tietz fundamental of clinical chemistry

  2016cited by this paper
• Use of the combined first‐trimester screen result and low PAPP‐A to predict risk of adverse fetal outcomes

  2008cited by this paper
• Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction.

  2008cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cited by this paper
• Tietz clinical guide to laboratory tests.

  2006cited by this paper
• Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein.

  2006cited by this paper
• Prediction of pre‐eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy‐associated plasma protein‐A, free β‐human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation

  2006cited by this paper
• Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes.

  2006cited by this paper
• Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.

  2005cited by this paper
• PAPP-A: a marker of plaque instability. Is it ready for prime time?

  2005cited by this paper
• Serum Plasma Pregnancy-Associated Protein A: A Potential Marker of Echogenic Carotid Atherosclerotic Plaques in Asymptomatic Hyperlipidemic Subjects at High Cardiovascular Risk

  2003cited by this paper
• Validation of an Automated Immunoturbidimetric Assay for Measurement of Plasma D-Dimer

  2003cited by this paper
• Electrocardiographic diagnosis of acute myocardial infarction.

  2002cited by this paper
• Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.

  2001cited by this paper
• C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study: Are Inflammation and Fibrin Turnover Linked in Pathogenesis?

  2001cited by this paper
• Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction.

  2000cited by this paper
• The insulin-like growth factor axis: A review of atherosclerosis and restenosis.

  2000cited by this paper
• D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain.

  2000cited by this paper
• Use Of Fibrinogen and Fibrin D-Dimer in Prediction of Arterial Thrombotic Events

  1999cited by this paper
• Thrombogenic factors and recurrent coronary events.

  1999cited by this paper
• Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants

  1998cited by this paper
• Fibrin D-dimer, Tissue Plasminogen Activator, Plasminogen Activator Inhibitor, and the Risk of Major Ischaemic Heart Disease in the Caerphilly Study

  1998cited by this paper
• Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.

  1997cited by this paper
• Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.

  1996cited by this paper
• Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production.

  1996cited by this paper
• Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study.

  1995cited by this paper
• Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.

  1995cited by this paper
• Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

  1994cited by this paper
• Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.

  1993cited by this paper
• Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

  1993cited by this paper
• A macro and micro view of coronary vascular insult in ischemic heart disease.

  1990cited by this paper
• Antigenic constituents in pregnancy plasma which are undetectable in normal non-pregnant female or male plasma.

  1972cited by this paper
• O R I G I N a L C L I N I C a L I N V E S T I G a T I O N Open Access

  year unknowncited by this paper

• PAPP-A Protein Diagnostic and Prognostic Significance in Acute Coronary Syndromes Without Persistent ST-T-Segment Elevation.

  2026cites this paper
• Postmortem biochemistry in deaths from ischemic heart disease.

  2023cites this paper
• Relationship between Pregnancy-associated Plasma Protein-A and tissue factor levels in the coronary circulation of patients with acute coronary syndrome.

  2018cites this paper
• Direct Immunoassay for Free Pregnancy-Associated Plasma Protein A (PAPP-A).

  2018cites this paper
• Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction

  2017influential citation
• Predictive value of plasma D-Dimer and fibrinogen degradation products on prognosis of acute coronary syndrome

  2016cites this paper